Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rep. Pallone Has Cosmetics Concerns, Possibly Coming To A Storefront Near You

Executive Summary

Standing in front of a Claire's store in his home state, the New Jersey Democrat asked FDA Feb. 2 to investigate reports of asbestos-contaminated children's makeup products and provide a briefing on the issue and broader cosmetic safety concerns by Feb. 22.

Advertisement

Related Content

Capitol Hill Calm On Regulatory Front Before Mid-Term Elections Storm
IFRA North America Reborn As Fragrance Creators Association, Emphasizing Human Element
FDA FY 2019 Budget Justification Light On Cosmetics Progam Details
FDA To Try Its Hand At Sunscreen Absorption Study, A MUsT For TEA Sponsors
PCPC Wants Cosmetics Reform Passed Before Threatened 'Blue Wave'
House Bill Seeks Asbestos Warnings On Unverified Kids' Cosmetics With Talc
Rep. Pallone Keeps After Cosmetics; Edgewell Acquires Jack Black; Coty On Amazon Echo; News In Brief
Rep. Pallone's Push For Cosmetics Reform Falls Flat During OTC Monograph Bill Markup
Claire's Scare Revives Concerns About Asbestos-Tainted Kids' Cosmetics
Rep. Pallone Galvanized By FDA's 'Troubling Overview' Of Cosmetic Imports

Topics

Advertisement
UsernamePublicRestriction

Register

RS121449

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel